Skip to main content

Table 1 Intra-group and inter-group differences in the first follow up (from the beginning of the treatment to 9 months) and in the second follow-up (from the beginning of the treatment to 18 months)

From: Clinical and radiographic evaluation of biodentine versus calcium hydroxide in primary teeth pulpotomies: a retrospective study

 

Calcium hydroxide

9 months

Biodentine

9 months

Calcium hydroxide

18 months

Biodentine

18 months

Intra-group

p- value

CH

(OR: CI 95%)

Intra-group

p- value

Biodentine

OR CI 95%

Inter-group

p- value

9 months

OR CI 95%

Inter-group

p- value

18 months

OR CI 95%

Sex

91 males, 80 females,

98 males, 90 females,

88 males, 75 females,

94 males, 85 females,

 

Age (years)

7.7 ± 1.6

7.5 ± 1.5

7.5 ± 1.5

7.6 ± 1.7

 

Total success

171 (85.5%)

188 (94%)

163 (81.5%)

179 (89.5%)

0.28 (1.34: 0.79–2.28)

0.1 (1.84: 0.88–3.85)

0.005* (0.38: 0.19–0.76)

0.02* (0.52: 0.29–0.92)

Clinical success

182 (91%)

195 (97.5%)

179 (89.5%)

193 (96.5%)

0.61 (1.19: 0.61–2.3)

0.56 (1.41:0.44–4.53)

0.005* (0.26: 0.09–0.71)

0.006* (0.31: 0.13–0.74)

Radiographic success

171 (85.5%)

188 (94%)

166 (83%)

181 (90.5%)

0.49 (1.21:0.7–2.07)

0.19 (1.64:0.78–3.48)

0.005* (0.38: 0.19–0.76)

0.027* (0.51: 0.28–0.93)

Pain

11 (5.5%)

2 (1%)

13 (6.5%)

3 (1.5%)

0.67 (0.84:0.37–1.92)

0.65 (0.66:0.11–4.01)

0.011* (5.76:1.26–26.34)

0.01* (4.57: 1.28–16.28)

Percussion

9 (4.5%)

1 (0.5%)

9 (4.5%)

2 (1%)

1 (1:0.39–2.57)

0.56 (0.5:0.04–5.53)

0.01* (9.38:1.18–74.72)

0.03* (4.66: 1–21.87)

Swelling

12 (6%)

1 (0.5%)

12 (6%)

1 (0.5%)

1 (1: 0.44–2.28)

1 (1:0.06–16.1)

0.002* (12.7:1.64–98.64)

0.002* (12.7: 1.64–98.64)

Mobility

2 (1%)

1 (0.5%)

3 (1.5%)

1 (0.5%)

0.65 (0.11–4.01)

1 (1:0.06–16.1)

0.56 (2.01:0.18–22.35)

0.32 (3.03:0.31–29.38)

Esfoliation

16 (8%)

6 (3%)

18 (9%)

9 (4.5%)

0.72 (0.88:0.43–1.78)

0.43 (0.66:0.23–1.88)

0.028* (2.81:1.08–7.34)

0.07 (2.1:0.92–4.79)

Widening

13 (6.5%)

5 (2.5%)

16 (8%)

8 (4%)

0.56 (0.8:0.37–1.71)

0.4 (0.62:0.2–1.91)

0.054* (2.71: 0.95–7.75)

0.09 (2.09:0.87–4.99)

Resorption

14 (7%)

5 (2.5%)

17 (8.5%)

8 (4%)

0.57 (0.81:0.39–1.69)

0.4 (0.62:0.2–1.91)

0.034* (2.94:1.04–8.31)

0.06 (2.23:0.94–5.29)

Radiolucency

2 (1%)

2 (1%)

0 (0%)

3 (1.5%)

0.16 (0)

0.65 (0.66:0.11–4.01)

1 (1:0.14–7.17)

0.08 (0)

  1. Chi-square test *p < 0.05